Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

1.

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

Lönneborg A.

Mol Diagn Ther. 2008;12(5):307-20. Review.

PMID:
18803429
[PubMed - indexed for MEDLINE]
2.

Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful?

Borroni B, Di Luca M, Padovani A.

Eur J Pharmacol. 2006 Sep 1;545(1):73-80. Epub 2006 Jun 16. Review.

PMID:
16831417
[PubMed - indexed for MEDLINE]
3.

[Biomarkers in cerebrospinal fluid and blood in memory complaints].

Zetterberg H, Andreasen N, Blennow K.

Lakartidningen. 2009 May 13-19;106(20):1386-9. Review. Swedish. No abstract available.

PMID:
19585836
[PubMed - indexed for MEDLINE]
4.

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.

Marksteiner J, Hinterhuber H, Humpel C.

Drugs Today (Barc). 2007 Jun;43(6):423-31. Review.

PMID:
17612711
[PubMed - indexed for MEDLINE]
5.

[Biochemical markers for Alzheimer disease].

Czarna JM, Waldemar G, Heegaard NH.

Ugeskr Laeger. 2006 Mar 6;168(10):1010-4. Review. Danish.

PMID:
16522291
[PubMed - indexed for MEDLINE]
6.

Biomarkers for Alzheimer's disease.

Sonnen JA, Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ.

Expert Rev Neurother. 2007 Aug;7(8):1021-8. Review.

PMID:
17678497
[PubMed - indexed for MEDLINE]
7.

Biomarkers of mild cognitive impairment and Alzheimer's disease.

Tang BL, Kumar R.

Ann Acad Med Singapore. 2008 May;37(5):406-10.

PMID:
18536828
[PubMed - indexed for MEDLINE]
Free Article
8.

Biochemical markers in persons with preclinical familial Alzheimer disease.

Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL.

Neurology. 2008 Jul 8;71(2):85-92. doi: 10.1212/01.wnl.0000303973.71803.81. Epub 2008 May 28.

PMID:
18509095
[PubMed - indexed for MEDLINE]
9.

Laboratory biomarkers in Alzheimer's disease.

Steinerman JR, Honig LS.

Curr Neurol Neurosci Rep. 2007 Sep;7(5):381-7. Review.

PMID:
17764627
[PubMed - indexed for MEDLINE]
10.

Neurochemical dementia diagnostics: State of the art and research perspectives.

Lewczuk P, Wiltfang J.

Proteomics. 2008 Mar;8(6):1292-301. doi: 10.1002/pmic.200700703. Review.

PMID:
18271068
[PubMed - indexed for MEDLINE]
11.

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K.

JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064.

PMID:
19622817
[PubMed - indexed for MEDLINE]
12.

Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.

Schneider P, Hampel H, Buerger K.

CNS Neurosci Ther. 2009 Winter;15(4):358-74. doi: 10.1111/j.1755-5949.2009.00104.x. Epub 2009 Oct 14. Review.

PMID:
19840034
[PubMed - indexed for MEDLINE]
13.

Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical setting.

Lanari A, Parnetti L.

ScientificWorldJournal. 2009 Sep 15;9:961-6. doi: 10.1100/tsw.2009.106.

PMID:
19768352
[PubMed - indexed for MEDLINE]
Free Article
14.

CSF biomarker profile and diagnostic value in vascular dementia.

Paraskevas GP, Kapaki E, Papageorgiou SG, Kalfakis N, Andreadou E, Zalonis I, Vassilopoulos D.

Eur J Neurol. 2009 Feb;16(2):205-11. doi: 10.1111/j.1468-1331.2008.02387.x.

PMID:
19146641
[PubMed - indexed for MEDLINE]
15.

Biomarkers in preclinical Alzheimer's disease.

Chong MS, Lim WS, Sahadevan S.

Curr Opin Investig Drugs. 2006 Jul;7(7):600-7. Review.

PMID:
16869111
[PubMed - indexed for MEDLINE]
16.

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.

PMID:
19273758
[PubMed - indexed for MEDLINE]
17.

Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

Jellinger KA, Janetzky B, Attems J, Kienzl E.

J Cell Mol Med. 2008 Aug;12(4):1094-117. doi: 10.1111/j.1582-4934.2008.00313.x. Epub 2008 Mar 19. Review.

PMID:
18363842
[PubMed - indexed for MEDLINE]
18.

[Alzheimer's and related diseases: toward earlier and more accurate diagnosis].

Fortin MP, Krolak-Salmon P.

Rev Med Interne. 2010 Dec;31(12):846-53. doi: 10.1016/j.revmed.2010.08.006. Epub 2010 Oct 16. French.

PMID:
20952104
[PubMed - indexed for MEDLINE]
19.

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

Simonsen AH, McGuire J, Podust VN, Davies H, Minthon L, Skoog I, Andreasen N, Wallin A, Waldemar G, Blennow K.

Neurobiol Aging. 2008 Jul;29(7):961-8. Epub 2007 Feb 23.

PMID:
17321007
[PubMed - indexed for MEDLINE]
20.

Biomarkers of Alzheimer's disease in body fluids.

Zheng Y, He J, Hong T.

Sci China Life Sci. 2010 Apr;53(4):490-6. doi: 10.1007/s11427-010-0081-9. Epub 2010 May 7. Review.

PMID:
20596916
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk